ILAG (ILAG) Stock Price & Analysis
ILAG (ILAG) rose 3.26% to USD 3.73 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
ILAG last closed at USD 3.61; the session ranged USD 3.65–3.73 on volume of 1,181 shares. Market capitalization is $7.75M, with a 52-week range of USD 2.04–9.56 (NCM). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 3.73 |
|---|---|
| Change | ▲ 3.26% (up) |
| Previous Close | USD 3.61 |
| Open | USD 3.66 |
| Day Range | USD 3.65 – 3.73 |
| 52-Week Range | USD 2.04 – 9.56 |
| Volume | 1,181 shares |
| Market Cap | $7.75M |
| Exchange | NCM |
Technical Analysis (ILAG)
Nexqual's technical model rates ILAG "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.87 (neutral) |
| vs SMA50 | Above (USD 3.66) |
| MACD | -0.04 (negative) |
Analyst Ratings (ILAG)
Wall Street analysts rate ILAG "None", per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | None |
|---|
Earnings (ILAG)
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (ILAG)
| Total Revenue | $4.49M |
|---|---|
| Revenue Growth (YoY) | -27.90% |
| Gross Margin | +2.89% |
| Operating Margin | -511.54% |
| Profit Margin | +0.00% |
| ROE | -221.18% |
| Debt / Equity | 37.85 |
| Current Ratio | 1.97 |
| Total Cash | $645,939 |
| Total Debt | $1.84M |
| Free Cash Flow | $-5.82M |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (ILAG)
Nexqual rates ILAG's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Critical — Revenue -28% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $646K cash vs $2M debt |
| Cash Flow | Weak — FCF negative: -$6M, burning cash |
| Efficiency | Critical — ROE -221%, ROA -90.3% |
Ownership (ILAG)
| Insider Ownership | +52.48% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 2.08M |
| Float | 986,446 |
| Short % of Float | +0.56% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (ILAG)
ILAG is led by Yu Bong Lau (age 46), CEO & Chairman of the Board, per Nexqual as of June 10, 2026 at 00:51 UTC.
| CEO & Chairman of the Board | Yu Bong Lau (age 46) |
|---|---|
| COO & Director | Yu Bun Lau (age 43) |
| CTO & Director | Po Wang Hui (age 73) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEGL | Magic Empire Global Limited | USD 1.29 | ▲ 5.74% |
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| ATXG | Addentax Group Corp. | USD 4.35 | ▼ 13% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.95 | ▲ 10.24% |
| VRAX | Virax Biolabs Group Limited | USD 0.19 | ▼ 11.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.